The Gene Expression Levels of ETS2, ADAM28, and GPRC5D Genes in Acute Lymphoblastic Leukemia Patients
نویسندگان
1 Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran - Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
2 Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran - Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
3 Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran - Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
4 Thalassemia & Hemoglobinopathy Research Center, Health research institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran - Thalassemia & Hemoglobinopathy Research Center, Health research institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
5 Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran - Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
6 Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran - Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
7 Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran - Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
8 Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran - Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
doi
10.18502/ijpho.v15i1.17279چکیده
Background: Genetic biomarkers significantly influence the pathological differentiation and proliferation of lymphoid precursor cells, contributing to the development of Acute Lymphoblastic Leukemia (ALL) in children. This case-control study aimed to assess the expression levels of three potential biomarkers: ETS2, ADAM28, and GPRC5D, in patients with ALL. Materials and Methods: In ...
